11 March 2002
Inflammatory bowel disease in Greece- a hospital-based clinical study of 172 consecutive patients.
Apostolos Giontzis, Panagiotis Davaris, Athanasios J Archimandritis, Pantelis Grigoriadis, Stavros Sougioultziz, Dimitris Kourtesas, Michalis TzivrasMed Sci Monit 2002; 8(3): CR158-164 :: ID: 420910
Abstract
BACKGROUND: It has been suggested that inflammatory bowel disease (IBD)has a milder course in Greece than in other Western countries. The purpose of our study was to assessthe clinical picture of IBD in a hospital-based sample of IBD patients, followed from January 1986 toMay 2001. MATERIAL/METHODS: Retrospective study of 172 patients: 130 with UC followed up for 1-360 months(mean 66±57 months) and 42 with CD for 1-240 months (mean: 51.85±63.68 months). RESULTS: 63 UC patients(48%) required hospitalization, 30 (23%) on the first attack; 72 (55%) had left sided colitis and 23(18%) pancolitis; in 6 cases, (5%), surgical intervention was indicated at onset, 4 (3%) were operated.During FU, 15 patients (11.5%) were operated, 4 (3%) as medical emergencies, 3 (2%) due to colon cancer,the others for intractable colitis or long-standing disease; 5 patients (4%) developed toxic dilationof the colon, 3 (2%) developed colon cancer and 4 (4%) extraintestinal malignancies. 7 patients (5%)died; 2 (1.5%) due to the disease and the remainder for other causes. 19 CD patients (45%) had ileocolitisand 14 (33%) colitis; 22 (52%) needed hospitalization on the first attack. In 12 patients (29%) surgicalintervention was required on initial onset or during FU. One patient developed colon cancer (2%). Twomen died (5%) from myocardial infarction. CONCLUSIONS: IBD does not have a milder course in Greece thanin other European populations.
Keywords: Adolescent, Aged, 80 and over, Colitis, Ulcerative, Crohn Disease, Greece, Hospitals, Inflammatory Bowel Diseases, Time Factors
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952